An Exceedingly Rare Case of Mechanobullous Epidermolysis Bullosa Acquisita in a Prepubertal Child: A Review of the Clinical and Laboratory Considerations [PDF]
Introduction: Epidermolysis bullosa acquisita (EBA) is a rare autoimmune disease causing subepithelial blistering due to autoantibodies against type VII collagen.
Aleksandra Wiktoria Bratborska +3 more
doaj +2 more sources
Complexities of care in a pediatric patient with epidermolysis bullosa acquisita and duchenne muscular dystrophy: a case report [PDF]
Background Type VII collagen autoantibodies drive epidermolysis bullosa acquisita (EBA), a rare autoimmune blistering disorder. While typically seen in adults, pediatric cases—especially those with additional comorbidities—present unique clinical ...
Khayry Al-Shami +7 more
doaj +2 more sources
Diagnosis of Epidermolysis Bullosa Acquisita: Multicentre Comparison of Different Assays for Serum Anti-type VII Collagen Reactivity [PDF]
Epidermolysis bullosa acquisita is a pemphigoid disease characterized by autoantibodies against type VII collagen. This study compared the sensitivity and specificity of 6 diagnostic assays: type VII collagen non-collagenous domains enzyme-linked ...
Maike M. Holtsche +9 more
doaj +2 more sources
Clinical Features of Paediatric Inflammatory Epidermolysis Bullosa Acquisita: A Case Series Study [PDF]
Epidermolysis bullosa acquisita (EBA) rarely develops in childhood. This study retrospectively recruited paediatric patients with EBA (age ≤ 16 years), diagnosed by clinical and histopathological features and results of immunofluorescence, immunoblotting
Yuexin Zhang +5 more
doaj +2 more sources
Inhibition of interferon gamma impairs induction of experimental epidermolysis bullosa acquisita [PDF]
Epidermolysis bullosa acquisita (EBA) is a muco-cutaneous autoimmune disease characterized and caused by autoantibodies targeting type VII collagen (COL7). The treatment of EBA is notoriously difficult, with a median time to remission of 9 months.
Natalie Gross +6 more
doaj +2 more sources
Epidermolysis Bullosa Acquisita
A 35 years old man presented with features of epidermolysis bullosa acquisita. Here is the case report.
Gangopadhyay Asok Kumar
doaj +3 more sources
IgM-mediated epidermolysis bullosa acquisita [PDF]
Sidney Harrison, BS +3 more
doaj +2 more sources
Epidermolysis bullosa acquisita: A report of four cases
Abhishek De +4 more
doaj +2 more sources
Whole-genome expression Profiling in skin reveals sYK as a Key regulator of inflammation in experimental epidermolysis Bullosa acquisita [PDF]
Because of the morbidity and limited therapeutic options of autoimmune diseases, there is a high, and thus far, unmet medical need for development of novel treatments.
Aga +57 more
core +10 more sources
In pemphigoid diseases, direct immunofluorescence can be used to differentiate 2 patterns of antibody deposition at the dermal–epidermal junction; u- and n-serrated pattern.
Maike M. Holtsche +5 more
doaj +1 more source

